Board of Directors

James R. Trusler

Chief Executive Officer, President, Chairman of the Board, Founder, Promoter, Director

Chairman of the Board of the Company, 1998 to present; CEO and President of the Company 1998-2018, 2019 to present; President, J. R. Trusler & Associates (mineral consultant), 1995 to present.

Lorne D. Burden

Director; Member, Compensation Committee

Consulting Geologist, 2014 to present; Manager Corporate Development/Senior Geologist Logistics Royal Nickel Corporation 2007 to 2014; Associate Consulting Geologist with ACA Howe International Limited, 2005-2007

Graham C. Warren, CPA, CMA

Director, Chair of the Audit Committee

Mr. Warren is a Senior Financial Executive with over 30 years of experience in the mining, oil and gas, environmental, service and tech sectors both domestically and internationally. He has been involved in numerous financings and M&A transactions for both private and public companies and has guided several companies through the going public process. Mr. Warren has served as CFO and/or Director of numerous public companies and is currently the CFO of Pangolin Diamonds Corp, Goliath Resources Limited. and a reporting issuer Arehada Mining Limited. He is a past director of Changfeng Energy Inc., Cordoba Minerals Corp, Exile Resources Inc., Active Control Technology and Hanfeng Evergreen Inc. Mr. Warren has had extensive involvement in all facets of organizations including finance, human resources, sales, marketing and operations and has guided boards in their corporate governance obligations.

Robert Schwartz

Director; Member, Compensation Committee

Robert Schwartz is and has been a serial entrepreneur with over 15 years of experience in manufacturing and global distribution as well as experience in financing micro-cap companies from inception/incubator stage to public markets. Mr. Schwartz is currently a director of Lineage Grow Company Ltd. (CSE BUDD) and is also a director at Aura Health Corp. Mr. Schwartz has invested, consulted or operated in over 15 cannabis companies internationally.

Gary Galitsky

Director; Member, Compensation Committee, Audit Committee

Gary Galitsky is the President and a Director of Xanthic Biopharma Inc. (CSE: XTHC). Mr. Galitsky has been producing craft cannabis for designated use for 7 years and has extensive expertise in cannabis extraction techniques. Mr. Galitsky was one of the earliest applicants to receive a Canadian Marihuana Medical Access Regulations license for both personal and designated production. He has consulted for several licensed medical cannabis producers to develop both scaled plant production growth strategy as well as extraction and secondary processes.